ArticleHemaSphere2025

Long-term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients.

Rita Tavarozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.